{
    "code": "02017531",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02017531",
    "time": "2019-09-27 03:28:28",
    "許可證字號": "衛署藥輸字第017531號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/03\/16",
    "註銷理由": "自請註銷",
    "有效日期": "108\/07\/06",
    "發證日期": "78\/10\/24",
    "許可證種類": "製　劑",
    "舊證字號": "02006442",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201753100",
    "中文品名": "&quot;葛蘭素&quot; 西力欣２５０公絲注射劑",
    "英文品名": "ZINACEF 250MG INJECTION &quot;GLAXO&quot;",
    "適應症": "葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症",
    "劑型": "240乾粉注射劑",
    "包裝": "250公絲小瓶 每盒100支以下小瓶",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "CEFUROXIME (SODIUM)",
    "主製造廠": {
        "申請商名稱": "0901801100  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
        "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
        "主製造廠": "",
        "製造廠名稱": "FIT0339100  GLAXOSMITHKLINE MANUFACTURING S.P.A."
    },
    "CCC號列": "30042000319 人用醫藥製劑，含頭孢子菌類抗生素者Medicaments, containing cephalosporins, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812391110",
            "成分名稱": "CEFUROXIME (SODIUM)",
            "含量描述": "250",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020175310004.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017531&Seq=004&Type=9"
        }
    ]
}